Recent findings have demonstrated a significant inverse association of serum adiponectin with CVD risk in both the general population and patients with DM, establishing the hypothesis that a higher serum adiponectin level might be predictive of a lower CVD risk2. Here, ADIPOQ is linked to diabetes mellitus.